Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(505/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Oxadiazoles
Feb 03, 2020
PTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy
Oct 04, 2019
PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna(TM) (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy
Jun 28, 2019
PTC Provides Update on Translarna(TM) (ataluren) Application for Label Expansion
Apr 29, 2019
Translarna(TM) (ataluren) is the First Therapy Approved in Brazil for Duchenne Muscular Dystrophy
Oct 06, 2018
PTC Therapeutics Announces Initial Data from Patient Registry Demonstrating Translarna(TM) (ataluren) Slows Disease Progression in Children with Duchenne Caused by a Nonsense Mutation
Jul 09, 2018
PTC Therapeutics Announces Positive Data from its Translarna(TM) Phase II Clinical Trial in Children as Young as Two Years with Nonsense Mutation Duchenne Muscular Dystrophy
Feb 20, 2018
PTC Therapeutics Receives Formal Dispute Resolution Request Decision from the FDA's Office of New Drugs
Oct 25, 2017
PTC Therapeutics Receives Complete Response Letter for Ataluren's NDA
Sep 12, 2017
Now Available in Canada: ISENTRESS® HD (raltegravir), a New Once-Daily Option, in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection in Appropriate Patients
Aug 08, 2017
PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Jun 22, 2017
New Analyses of Translarna(TM) (ataluren) Data from ACT DMD Presented at the 12th Annual European Pediatric Neurology Society Congress
Jun 06, 2017
PTC Therapeutics Announces FDA Advisory Committee Meeting for Ataluren for the Treatment of Nonsense Mutation Dystrophinopathy
Latest News
Apr 19, 2024
Xylem to Host Investor Day on May 30, 2024
Apr 19, 2024
VOC Energy Trust Announces Trust Quarterly Distribution
Apr 19, 2024
Primoris Services Corporation Schedules First Quarter 2024 Earnings Conference Call and Webcast
Apr 19, 2024
AV’s Switchblade 300 Selected for U.S. Marine Corps’ Organic Precision Fires-Light Program
Apr 19, 2024
Rocket Lab Announces Board Change
Apr 19, 2024
XPEL, Inc. to Host Conference Call to Discuss First Quarter 2024 Results
Apr 19, 2024
Nextracker to Announce Fourth Quarter Fiscal 2024 and Full-Year Results on May 14, 2024
Apr 19, 2024
Flux Power Appoints Mark Leposky to Board of Directors
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events